Abstract
Objective: To assess the short-term clinical and radiographic outcomes of the reverse total shoulder arthroplasty. Methods: After FDA approval of the reverse total shoulder arthroplasty (TSA) in 2004, a consecutive series of the first sixty-two patients treated with this prosthesis by a single surgeon was prospectively initiated through an IRB-approved protocol. All patients presented with signs and symptoms of painful glenohumeral arthritis combined with severe rotator cuff deficiency, anterosuperior shoulder instability, and/or a painful, dysfunctional failed shoulder arthroplasty.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
